60% of endometrial cancer cases are co-mutated in KRAS and PI3KCA, yet only 7% of colorectal cancer patients exhibit these co-mutations (Oda et al., 2008; Voutsadakis, 2023). The gene discussed is KRAS; the disease is colorectal cancer.